“And then earlier this year, the FDA says Ozempic and…” — The Daily at 17:52
“And then earlier this year, the FDA says Ozempic and Wagovi, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. The FDA has ordered compounding pharmacies to largely stop selling their version of the drugs. The FDA said these drugs are no longer on the shortage list and they told…”
0:00
22:34